Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia

Journal of Clinical Oncology

Volumn 14, Issue 8, 1996, Pages 2370-2376

  Ito, C ^a   Evans, W E ^a   McNinch, L ^a   Coustan Smith, E ^a   Mahmoud, H ^a   Pui, C H ^a   Campana, D ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; PREDNISOLONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; INFANT; LEUKEMIA CELL; PRIORITY JOURNAL; STROMA;

EID: 0029836218     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.8.2370     Document Type: Article

References (30)

1. Gaynon PS, Lustig RH: The use of glucocorticoids in acute lymphoblastic leukemia of childhood. Molecular, cellular, and clinical considerations, J Pediatr Hematol Oncol 17:1-12, 1995
2. Fauci AS, Dale DC, Balow JE: Glucocorticosteroid therapy: Mechanisms of action and clinical considerations. Ann Intern Med 84:304-315, 1976
3. Claman HN: Glucocorticosteroids II: The clinical responses. Hosp Pract 18:143-151, 1983
4. Nelson DH: Pharmacology of the corticosteroids and adrenocorticotropic hormone, in Bevan JA, Thompson JH (eds): Essentials of Pharmacology. Philadelphia, PA, Harper & Row, 1983, pp 469-476
5. Marble A, Weir GC, Selenkow HA, et al: Endocrine diseases, in Speight TM (ed): Avery's Drug Treatment. Baltimore, MD, Williams & Wilkins. 1987, pp 522-590
6. Kaspers GJ, Veerman AJ, Van Zantwijk CH, et al: Activity of prednisolone and dexamethasone in childhood acute lymphoblastic leukemia assessed using the MTT assay. Haematologica 76:47, 1991 (suppl 4; abstr)
7. Pieters R, Kaspers GJ, Van Wering ER, et al: Dexamethasone in much more potent than prednisolone in the assumed equivalent doses in childhood leukemia. Proc Am Soc Clin Oncol 11:A938, 1992 (abstr)
8. Kaspers GJL, Pieters R, Klumper E, et al: Glucocorticoid resistance in childhood leukemia. Leuk Lymphoma 13:187-201, 1994
9. Veerman AJP, Hahlen K, Kamps WA, et al: Results of the ALL-VI protocol for non-high risk childhood acute lymphoblastic leukemia from the Dutch Childhood Leukemia Study Group. Haematologica 76:105, 1991 (suppl 4; abstr)
10. Manabe A, Coustan-Smith E, Behm F, et al: Bone marrow derived stromal cells prevent apoptotic cell death in B lineage acute lymphoblastic leukemia. Blood 79:2370-2377, 1992
11. Campana D, Manabe A, Evans WE: Stroma-supported immunocytometric assay (SIA): A novel method for testing the sensitivity of acute lymphoblastic leukemia cells to cytotoxic drugs. Leukemia 7:482-488, 1993
12. Manabe A, Murti KG, Coustan-Smith E, et al: Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells. Blood 83:758-766, 1994
13. Manabe A. Yi T, Kumagai M, et al: Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. I. Cytotoxicity of interferon alpha in acute lymphoblastic leukemia. Leukemia 7:1900-1905, 1993
14. Manabe A, Coustan-Smith E, Kumagai M, et al: Interleukin-4 induces programmed cell death (apoptosis) in cases of high risk acute lymphoblastic leukemia. Blood 83:1731-1737, 1994
15. Kumagai M, Manabe A, Coustan-Smith E, et al: Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. II. Potent cytotoxicity of 2-chloro-deoxyadenosine in acute lymphoblastic leukemia. Leukemia 8:1116-1123, 1994
16. Kumagai M, Coustan-Smith E, Murry DJ, et al: Ligation of CD38 suppresses human B lymphopoiesis. J Exp Med 181:1101-1110, 1995
17. Kumagai M, Manabe A, Pui C-H, et al: Growth of childhood B-lineage acute lymphoblastic leukemia cells on bone marrow stroma as a predictor of treatment outcome. J Clin Invest 97:755-760, 1996
18. DeLean A, Munson PJ, Rodbord D: Simultaneous analysis of families of sigmoid curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235:E97-E102.27, 1978
19. Gold R. Schmied M, Rothe G, et al: Detection of DNA fragmentation in apoptosis: Application of in situ nick translation to cell culture systems and tissue sections. J Histochem Cytochem 41:1023-1030, 1993
20. Grand RJA, Milner AE, Mustoe T, et al: A novel protein expressed in mammalian cells undergoing apoptosis. Exp Cell Res 218:439-451, 1995
21. Coustan-Smith E, Kitanaka A, Pui C-H, et al: Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia. Blood 87:1140-1146, 1996
22. Kontula K, Andersson LC, Paavonen T, et al: Glucocorticoid receptors and glucocorticoid sensitivity of human leukemic cells. Int J Cancer 26:177-183, 1980
23. Schmidt TJ, Harmon JM, Thompson EB: "Activation-labile" glucocorticoid-receptor complexes of a steroid-resistant variant of CEM-C7 human lymphoid cells. Nature 286:507-510, 1980
24. Telford WG, King LE, Fraker PJ: Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif 24:447-459, 1991
25. Distelhorst CW: Glucocorticosteroids induce DNA fragmentation in human lymphoid leukemia cells. Blood 72:1305-1309, 1988
26. Kaspers GJL, Pieters R, Zantwijk CH, et al: Acute lymphoblastic leukemia and acute non-lymphoblastic leukemia: Differences in cellular drug resistance, with emphasis on glucocorticoids - A pilot study. Haematol Bloodtransf 35:452-456, 1994
27. Kaspers GJL, Veerman AJP, Pieters R, et al: Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay. Br J Cancer 70:1047-1052, 1994
28. Sugahara H, Kanahura Y, Furitsu T, et al: Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5. J Exp Med 179:1757-1766, 1994
29. Balis FM, Lester CM, Chrousos GP, et al: Differences in cerebrospinal fluid penetration of corticosteroids: Possible relationship to the prevention of meningeal leukemia. J Clin Oncol 5:202-207, 1987
30. Jones B, Freeman AI, Shuster JJ, et al: Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia. Med Pediatr Oncol 19:269-275, 1991